Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

FDA Analysis of Screen Failures By Race in Clinical Trials of Acute Myeloid Leukemia

Dianne Pulte, MD, Guo Wei, Kelly J. Norsworthy, MD, Yutao Gong, PhD, Nicole J. Gormley, MD, Bindu Kanapuru, MD, Richard Pazdur, MD, Julie Schneider, Marc Theoret, MD, Angelo De Claro, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-136363

Published: 2020

Journal Articles

FDA Analysis: Impact of Body Mass Index (BMI) on Outcomes in Relapsed-Refractory Multiple Myeloma

Rachel Ershler, MD, Bindu Kanapuru, MD, Yutao Gong, PhD, Urvi A Shah, MD, Sham Mailankody, MBBS, Ola Landgren, MD PhD, Marc Theoret, MD, Nicole J Gormley, MD, Ann T. Farrell, MD, Richard Pazdur, MD

Blood (2019) 134 (Supplement_1): 5505.

https://doi.org/10.1182/blood-2019-130551

Published: 2019

Journal Articles

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

Janice Kim, PharmD, MSc, Bindu Kanapuru, MD, Jessica K Roydhouse, PhD MPH, Ann T. Farrell, MD, Najat Bouchkouj, MD, Hussein Ezzeldin, PhD, Paul Kluetz, MD

Blood (2019) 134 (Supplement_1): 3450.

https://doi.org/10.1182/blood-2019-125798

Published: 2019

Journal Articles

FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug Regimens

Bindu Kanapuru, MD, Susan Jin, Kunthel By, Theresa Carioti, Yuan-Li Shen, PhD, Rajeshwari Sridhara, PhD, Nicole J Gormley, MD, Ann T. Farrell, MD, Richard Pazdur, MD

Blood (2019) 134 (Supplement_1): 3194.

https://doi.org/10.1182/blood-2019-127141

Published: 2019

Journal Articles

Hydroxyurea Utilization Patterns Among Sickle Cell Disease Patients in the United States, US FDA Sentinel Database

Rosanna Setse, MD MPH, PhD, Corinne Woods, RPh, MPH, Bindu Kanapuru, MD, Talia Menzin, BS, Justin Bohn, Sc.M., Sc.D, Justin Mathew, PharmD, David Coyle, MD, Barry W. Miller, MS, CNP, Ann T. Farrell, MD

Blood (2018) 132 (Supplement 1): 2372.

https://doi.org/10.1182/blood-2018-99-116281

Published: 2018

Journal Articles

FDA Analysis of Outcomes in Older Adults with Relapsed or Refractory Multiple Myeloma

Bindu Kanapuru, MD, Susan Jin, Kunthel By, Yuan Li Shen, PhD, Theresa Carioti, Nicole Gormley, MD, Ann T. Farrell, MD, Richard Pazdur, MD

Blood (2018) 132 (Supplement 1): 3287.

https://doi.org/10.1182/blood-2018-99-118597

Published: 2018

Journal Articles

Enrollment of Older Adults in Clinical Trials Evaluating Patients with Hematologic Malignancies - the Food and Drug Administration (FDA) Experience

Bindu Kanapuru, MD, Harpreet Singh, MD, Adrian Myers, Julia A. Beaver, MD, Virginia Elaine Kwitkowski, MS,NP, Ann T. Farrell, MD, Richard Pazdur, MD

Blood (2017) 130 (Supplement 1): 861.

https://doi.org/10.1182/blood.V130.Suppl_1.861.861

Published: 2017

Journal Articles

Relative Survival of Older Patients with Indolent Lymphoma–Analysis From the SEER Database

Mamatha Prabhakar, MD, Bindu Kanapuru, MD, Ahmedin Jemal, Charles Hesdorffer, MBBCH, FCP(SA), William Ershler, MD, Dan L. Longo, MD, Jerome W Yates, MD, MPH

Blood (2011) 118 (21): 5214.

https://doi.org/10.1182/blood.V118.21.5214.5214

Published: 2011

NARROW

FDA Analysis of Screen Failures By Race in Clinical Trials of Acute Myeloid Leukemia

FDA Analysis: Impact of Body Mass Index (BMI) on Outcomes in Relapsed-Refractory Multiple Myeloma

2017-2018 Hematology Drug Approvals at the Food and Drug Administration (FDA): Communication of Patient-Reported Outcomes (PRO) Information in FDA Clinical Reviews and Prescribing Information (PI)

FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug Regimens

Hydroxyurea Utilization Patterns Among Sickle Cell Disease Patients in the United States, US FDA Sentinel Database

FDA Analysis of Outcomes in Older Adults with Relapsed or Refractory Multiple Myeloma

Enrollment of Older Adults in Clinical Trials Evaluating Patients with Hematologic Malignancies - the Food and Drug Administration (FDA) Experience

Relative Survival of Older Patients with Indolent Lymphoma–Analysis From the SEER Database

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only